Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00186082 · ClinicalTrials.gov registry record · NA

Antibiotics for Postpartum Third and Fourth Degree Perineal Tear Repairs

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
147
Enrollment target

NCT00186082: Completed NA study, sponsored by Stanford University.

NCT00186082 is a NA study that has completed, run by Stanford University. The registered enrollment target is 147 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00186082, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
147 participants
Enrollment target

Study Summary

This study is undertaken to find out whether prophylactic antibiotics can decrease the infection rate in third and fourth degree perineal tear repairs done in the immediate postpartum period.

Interventions

  • DRUG Cefotetan or Cefoxitin vs placebo

Trial Details

FieldValue
Enrollment Target 147 participants
Start Date 2003-09
Est. Completion 2008-06
Phase NA
Stanford University

1,744 total trials

What the finished NCT00186082 record still lists

NCT00186082 is an interventional study that assigns participants to a tested intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 1 intervention - of which Cefotetan or Cefoxitin vs placebo is the first listed.

NCT00186082 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00186082 about?

NCT00186082 is a clinical study titled "Antibiotics for Postpartum Third and Fourth Degree Perineal Tear Repairs". This study is undertaken to find out whether prophylactic antibiotics can decrease the infection rate in third and fourth degree perineal tear repairs done in the immediate postpartum period.

What is the current status of trial NCT00186082?

This trial is currently completed. It is a NA study. The enrollment target is 147 participants. The study started on 2003-09. Estimated completion is 2008-06.

What interventions are being tested in trial NCT00186082?

The interventions under investigation include: Cefotetan or Cefoxitin vs placebo (DRUG).

Who is sponsoring clinical trial NCT00186082?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00186082's enrollment target sits among peer trials

147 703rd of 2000 higher than 1,297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04396613 · 147 participants · NA

    Wound Closure Techniques in Primary Spine Surgery

  • NCT04851119 · 147 participants · Phase 1

    Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • NCT05523947 · 147 participants · Phase 1

    Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

  • NCT06121843 · 147 participants · Phase 1

    A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00186082, the US trial registry maintained by the National Library of Medicine. NCT00186082 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.